
Mediterraneibacter gnavus
DSM 108212
Name:
Mediterraneibacter gnavus (Moore et al. 1976) Togo et al. 2023
DSM No.:
108212 dsm-108212 dsm108212 dsm 108212 Mediterraneibacter gnavus
Strain designation:
H2_28
Isolated from:
human faeces
Country:
United Kingdom of Great Britain and Northern Ireland
Cambridgeshire
Cambridgeshire
Date of sampling:
17-01-2104
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; H2_28
Genbank accession numbers:
whole genome shotgun sequence: CYZG00000000
Cultivation conditions:
Medium 104 , strictly anaerobic, 37°C
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
additional information:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; H2_28. Human faeces. United Kingdom of Great Britain and Northern Ireland, Cambridgeshire. Taxonomy/description (30548). Sequence accession no. whole genome shotgun sequence: CYZG00000000.
Biosample SAMEA3545260; strain 2789STDY5608852 = H2_28
. (Medium 104, 37°C)Literature:
Risk group:
1 (+) (classification according to German TRBA)
Supplied as:
| Delivery form | Prices | ||
| Freeze Dried | 120,- € | ||
| Active culture on request | 280,- € | ||
| DNA | 180,- € | ||
| Price Category for this culture: 1 | |||
Freight and handling charges will be added. See price list.
Other cultures:
